Detalles de la búsqueda
1.
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial.
Ann Oncol
; 34(9): 772-782, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399894
2.
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.
Ann Oncol
; 28(9): 2264-2271, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28633425
3.
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials.
Ann Oncol
; 27(4): 699-705, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26609008
4.
A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.
Ann Oncol
; 27(3): 454-60, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26685010
5.
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.
Br J Cancer
; 109(10): 2579-86, 2013 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24169353
6.
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.
Ann Oncol
; 29(1): 23-25, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29088323
7.
A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer.
Ann Oncol
; 23(10): 2714-2719, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22553195
8.
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.
Clin Cancer Res
; 13(19): 5841-6, 2007 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17908977
9.
Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL.
Prostate Cancer Prostatic Dis
; 20(2): 221-227, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28117385
Resultados
1 -
9
de 9
1
Próxima >
>>